國立虎尾科技大學 |

Genome-wide CRISPR Screen Reveals Regulators of PI3K Inhibitor Resistance in Pancreatic Ductal Adenocarcinoma.

Record Type:	Language materials, manuscript : Monograph/item
Title/Author:	Genome-wide CRISPR Screen Reveals Regulators of PI3K Inhibitor Resistance in Pancreatic Ductal Adenocarcinoma./
Author:	Han, Han.
Description:	1 online resource (130 pages)
Notes:	Source: Dissertations Abstracts International, Volume: 85-03, Section: B.
Contained By:	Dissertations Abstracts International85-03B.
Subject:	Biology. -
Online resource:	click for full text (PQDT)
ISBN:	9798380367875

Genome-wide CRISPR Screen Reveals Regulators of PI3K Inhibitor Resistance in Pancreatic Ductal Adenocarcinoma.
Han, Han.

Genome-wide CRISPR Screen Reveals Regulators of PI3K Inhibitor Resistance in Pancreatic Ductal Adenocarcinoma. - 1 online resource (130 pages)

Source: Dissertations Abstracts International, Volume: 85-03, Section: B.

Thesis (Ph.D.)--State University of New York at Stony Brook, 2023.

Includes bibliographical references

Pancreatic ductal adenocarcinomas (PDACs) are resistant to systemic treatments including immunotherapy. Over 90% of PDACs have oncogenic KRAS mutations, and phosphoinositide 3- kinases (PI3Ks) are direct effectors of KRAS. Previously, we demonstrated that genetic ablation of PI3K isoform, Pik3ca in the KPC (KrasG12D; Trp53R172H; Pdx1-Cre) pancreatic cancer cell line induced complete tumor elimination by infiltrating T cells in a mouse model. However, clinical trials using PI3K inhibitors for PDAC patients exhibited limited efficacy due to drug resistance. To identify potential contributors to PI3K inhibitor resistance, we conducted an in vivo genome-wide gene-deletion screen using the Pik3ca-/- KPC (αKO) cells implanted in the mouse pancreas and identified propionyl-CoA carboxylase subunit B (PCCB) modulates PIK3CA-mediated immune evasion. Deletion of Pccb gene in αKO cells (named p-αKO) allowed tumor progression causing death of host mice even though p-αKO tumors are infiltrated with T cells. Single-cell RNA sequencing revealed that infiltrating clonally expanded T cells in p-αKO tumors were more exhausted as compared to T cells founds in αKO tumors. Blockade of PD-L1/PD1 interaction reversed T cell exhaustion, slowed tumor growth and improved the survival of mice implanted with p-αKO cells. These results indicate that propionyl-CoA carboxylase activity can modulate PIK3CA-regulated immune surveillance of PDAC.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2024

Mode of access: World Wide Web

ISBN: 9798380367875Subjects--Topical Terms:

599573
Biology.
Subjects--Index Terms:

CRISPR screenIndex Terms--Genre/Form:

554714
Electronic books.

Genome-wide CRISPR Screen Reveals Regulators of PI3K Inhibitor Resistance in Pancreatic Ductal Adenocarcinoma.
LDR:02908ntm a22004217 4500 001 1142000
005 20240414211918.5
006 m o d
007 cr mn ---uuuuu
008 250605s2023 xx obm 000 0 eng d
020 $a 9798380367875
035 $a (MiAaPQ)AAI30310979
035 $a AAI30310979
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Han, Han. $3 1466134
245 1 0 $a Genome-wide CRISPR Screen Reveals Regulators of PI3K Inhibitor Resistance in Pancreatic Ductal Adenocarcinoma.
264 0 $c 2023
300 $a 1 online resource (130 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Dissertations Abstracts International, Volume: 85-03, Section: B.
500 $a Advisor: Lin, Richard Z.
502 $a Thesis (Ph.D.)--State University of New York at Stony Brook, 2023.
504 $a Includes bibliographical references
520 $a Pancreatic ductal adenocarcinomas (PDACs) are resistant to systemic treatments including immunotherapy. Over 90% of PDACs have oncogenic KRAS mutations, and phosphoinositide 3- kinases (PI3Ks) are direct effectors of KRAS. Previously, we demonstrated that genetic ablation of PI3K isoform, Pik3ca in the KPC (KrasG12D; Trp53R172H; Pdx1-Cre) pancreatic cancer cell line induced complete tumor elimination by infiltrating T cells in a mouse model. However, clinical trials using PI3K inhibitors for PDAC patients exhibited limited efficacy due to drug resistance. To identify potential contributors to PI3K inhibitor resistance, we conducted an in vivo genome-wide gene-deletion screen using the Pik3ca-/- KPC (αKO) cells implanted in the mouse pancreas and identified propionyl-CoA carboxylase subunit B (PCCB) modulates PIK3CA-mediated immune evasion. Deletion of Pccb gene in αKO cells (named p-αKO) allowed tumor progression causing death of host mice even though p-αKO tumors are infiltrated with T cells. Single-cell RNA sequencing revealed that infiltrating clonally expanded T cells in p-αKO tumors were more exhausted as compared to T cells founds in αKO tumors. Blockade of PD-L1/PD1 interaction reversed T cell exhaustion, slowed tumor growth and improved the survival of mice implanted with p-αKO cells. These results indicate that propionyl-CoA carboxylase activity can modulate PIK3CA-regulated immune surveillance of PDAC.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2024
538 $a Mode of access: World Wide Web
650 4 $a Biology. $3 599573
650 4 $a Bioengineering. $3 598252
650 4 $a Biomedical engineering. $3 588770
650 4 $a Oncology. $3 593951
650 4 $a Molecular biology. $3 583443
653 $a CRISPR screen
653 $a T cells
653 $a Pancreatic cancer
653 $a Immunotherapy
653 $a PI3K inhibitor resistance
655 7 $a Electronic books. $2 local $3 554714
690 $a 0306
690 $a 0202
690 $a 0992
690 $a 0541
690 $a 0307
710 2 $a ProQuest Information and Learning Co. $3 1178819
710 2 $a State University of New York at Stony Brook. $b Biomedical Engineering. $3 1466135
773 0 $t Dissertations Abstracts International $g 85-03B.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30310979 $z click for full text (PQDT)